Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis.

Abu-Fraiha Y, Elyashar-Earon H, Shoseyov D, Cohen-Cymberknoh M, Armoni S, Kerem E, Wilschanski M.

J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):110-115. doi: 10.1097/MPG.0000000000002126.

PMID:
30095576
2.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

3.

Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis.

Pugatsch T, Shoseyov D, Cohen-Cymberknoh M, Hayut B, Armoni S, Griese M, Kerem E.

Pediatr Pulmonol. 2016 Feb;51(2):143-6. doi: 10.1002/ppul.23344. Epub 2015 Nov 19.

PMID:
26583331
4.

CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation.

Tsabari R, Elyashar HI, Cymberknowh MC, Breuer O, Armoni S, Livnat G, Kerem E, Zangen DH.

J Cyst Fibros. 2016 May;15(3):e25-7. doi: 10.1016/j.jcf.2015.10.012. Epub 2015 Nov 4.

5.

Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity.

Breuer O, Cohen-Cymberknoh M, Armoni S, Kerem E, Shoseyov D.

Ann Allergy Asthma Immunol. 2014 Aug;113(2):229-30. doi: 10.1016/j.anai.2014.05.014. Epub 2014 Jun 13. No abstract available.

PMID:
24934107
6.

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.

Wilschanski M, Miller LL, Shoseyov D, Blau H, Rivlin J, Aviram M, Cohen M, Armoni S, Yaakov Y, Pugatsch T, Cohen-Cymberknoh M, Miller NL, Reha A, Northcutt VJ, Hirawat S, Donnelly K, Elfring GL, Ajayi T, Kerem E.

Eur Respir J. 2011 Jul;38(1):59-69. doi: 10.1183/09031936.00120910. Epub 2011 Jan 13. Erratum in: Eur Respir J. 2011 Oct;38(4):996. Pugatch, T [corrected to Pugatsch, T].

7.

Evidence of intestinal inflammation in patients with cystic fibrosis.

Werlin SL, Benuri-Silbiger I, Kerem E, Adler SN, Goldin E, Zimmerman J, Malka N, Cohen L, Armoni S, Yatzkan-Israelit Y, Bergwerk A, Aviram M, Bentur L, Mussaffi H, Bjarnasson I, Wilschanski M.

J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):304-8. doi: 10.1097/MPG.0b013e3181d1b013.

PMID:
20512061
8.

18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis.

Klein M, Cohen-Cymberknoh M, Armoni S, Shoseyov D, Chisin R, Orevi M, Freedman N, Kerem E.

Chest. 2009 Nov;136(5):1220-1228. doi: 10.1378/chest.09-0610. Epub 2009 Aug 20.

PMID:
19696124
9.

Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.

Cohen-Cymberknoh M, Blau H, Shoseyov D, Mei-Zahav M, Efrati O, Armoni S, Kerem E.

J Cyst Fibros. 2009 Jul;8(4):253-7. doi: 10.1016/j.jcf.2009.04.008. Epub 2009 May 15.

10.

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Cohen M, Nissim-Rafinia M, Blau H, Rivlin J, Aviram M, Elfring GL, Northcutt VJ, Miller LL, Kerem B, Wilschanski M.

Lancet. 2008 Aug 30;372(9640):719-27. doi: 10.1016/S0140-6736(08)61168-X. Epub 2008 Aug 20.

PMID:
18722008

Supplemental Content

Loading ...
Support Center